Kimberly-Clark (KMB) Launches New Product Safety Study

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the 10 Safest Dividend Stocks to Buy Right Now.

Kimberly-Clark (KMB) Launches New Product Safety Study

Kimberly-Clark Corporation (NASDAQ:KMB) provided an update on May 19, 2026, regarding its new clinical trial, “An Open-Label Applicator Tampon Safety-in-Use Study.” Actively recruiting volunteers, the study evaluates the safety of a commercially available tampon, designated as Tampon A, across regular, super, and super plus absorbencies during normal use. The trial runs an unblinded protocol and aims to de-risk product safety and reinforce consumer trust within Kimberly-Clark Corporation (NASDAQ:KMB)’s core feminine care division. The company has further reinforced its core product commitment on May 6, 2026, with the Natural Born Fighters campaign, launched by its own brand, Huggies. The campaign involves recognizing NICU babies’ strengths and supporting caregivers. Grounded in personalized care, it reframes fragile infants as Little Fighters.

Separately, Kimberly-Clark Corporation (NASDAQ:KMB) declared a regular quarterly dividend of $1.28 per share, payable on July 2, 2026, to shareholders of record as of June 5, 2026. The announcement made on May 12, 2026, highlights the company’s long-term financial stability and also marks its 92nd consecutive year of dividend payments and its 54th consecutive annual dividend increase.

​Founded in 1872, Kimberly-Clark Corporation (NASDAQ:KMB) is a global company focused on personal care products and solutions. Based in Texas, the company operates through two segments: North America and International Personal Care.

While we acknowledge the risk and potential of KMB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KMB and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Leopold Aschenbrenner’s Portfolio: 10 Best Stocks to Buy and Steve Cohen Stock Portfolio: Top 10 Stock Picks

Disclosure: None.  Follow Insider Monkey on Google News.

1281292 - 11759070 - 1